Key facts
- It has raised $400.0M across 2 recorded rounds; the latest was PIPE ($200.0M) in Sep 2021.
- 7 institutional filers report fund marks on Roivant Sciences across 30 filings.
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Roivant Sciences
Create free account
No card required
Funding rounds
2 roundsSep 2021PIPE$200.0M▮
Nov 2018PE Growth/Expansion$200.0M▮
About Roivant Sciences
- Industry
- Drug Discovery
PA Mark — not yet priced
Roivant Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Roivant Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
7 filers · latest Jun 20267 SEC-registered funds reported 30 fair-value marks on Roivant Sciences between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.